GBM84 GBM Model
GBM84, a Patient-Derived Xenograft (PDX) model, is your gateway to brain cancer research. Investigate its features to unlock new discoveries and advance the development of effective treatments. PDX models like GBM84 offer an indispensable platform for preclinical drug discovery. By preserving the genetic and histological features of the patient tumor, GBM84 enables researchers to evaluate a wide range of drug candidates efficiently. This accelerates the development of targeted therapies and holds promise for improved outcomes for brain cancer patients.
Model Details
Cancer Location: Intracranial
Cancer Type: Brain Cancer
Model Name: GBM84
Mouse Strain: Nu/Nu
Treatment Data Available: Chemotherapy (Temozolomide)
WES: Yes
RNAseq: Yes
Methylation: Yes
PDX Treatment: Yes
Patient Treatment History: Yes
GMB84 Survival
Survival of orthotopic intracranial implanted GBM84 in Nu/Nu mice (n=5)
